Safran (SAFRF) Earning Somewhat Critical News Coverage, Study Finds

Share on StockTwits

Headlines about Safran (OTCMKTS:SAFRF) have trended somewhat negative on Saturday, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than 6,000 news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Safran earned a media sentiment score of -1.19 on their scale. InfoTrie also gave news coverage about the company an news buzz score of 6 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company’s share price in the near future.

Shares of OTCMKTS:SAFRF traded down $4.43 during mid-day trading on Friday, hitting $126.70. 484 shares of the company traded hands, compared to its average volume of 619. Safran has a 12-month low of $101.25 and a 12-month high of $142.40.

ILLEGAL ACTIVITY WARNING: This article was first published by BBNS and is the sole property of of BBNS. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://baseballnewssource.com/2018/11/10/safran-safrf-earning-somewhat-critical-news-coverage-study-finds/2973541.html.

About Safran

Safran SA, together with its subsidiaries, engages in the aerospace and defense businesses worldwide. The company operates through three segments: Aerospace Propulsion, Aircraft Equipment, and Defense. The Aerospace Propulsion segment designs, develops, produces, and markets propulsion systems for commercial aircraft, military transport, training and combat aircraft, rocket engines, civil and military helicopters, and tactical missiles and drones.

Further Reading: What is the Dow Jones Industrial Average (DJIA)?

Receive News & Ratings for Safran Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safran and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.